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Insect-resistant Agb0101 rice was recently developed by modifying the cry1ac1 gene by changing 
codon usage changes relative to the native truncated cry1ac1 gene. To assess the toxicity of genetically 
modified Agb0101 rice, we conducted bioinfomational comparisons of the amino acid sequences that 
are not similar to known toxic proteins. Sufficient quantities of mCry1Ac1 protein were produced in 
Escherichia coli for in vitro evaluation and animal study. We compared the amino acid sequences and 
molecular mass. There have the same amino acid sequences and molecular masses after purifying the 
modified Cry1Ac1 (mCry1Ac1) protein from highly expressed bacteria and genetically modified rice 
were identical. We also investigated the acute and 90-days oral toxicities. No adverse effects were 
observed in mice following acute oral exposure to 2,000 mg/ kg body weight mCry1Ac1 protein of body 
weight and 90 days oral exposure to Agb0101. These results indicate that mCry1Ac1 proteins and 
Agb0101 rice demonstrate no adverse effects in these tests when applied via gavage and feed, 
respectively. 
 





Genetically modified (GM) crops are becoming an 
increasingly important feature of the agricultural land-
scapes. In 2013, approximately 175 million hectares of 
GM crops were planted by 18 million farmers in 27 
countries. Due to the unprecedented 100-fold increase 
between  1996  and  2013,  biotech  crops  are   now   the 
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Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, urea nitrogen; 
TG, triglyceride; A/G Ratio, albumin/globulin ratio; IP, inorganic phosphorus. 
 






fastest-adopted crop technology in the history of modern 
agriculture. Products with insect-resistant traits were the 
fastest growing group between 2009 and 2013 (James, 
2013). Rice (Oryza sativa) is an important crop and staple 
food that used to main energy source in Korea. Not only 
the major food but also economical impact, Rice production 
affects all around of Korea economy. In Korea, 1 million 
people are cultivating rice in about 1 million ha of rice 
field. Various factors limit rice productivity, including pest 
which annually destroy 20 to 30% of rice crops (Estruch 
et al., 1996). Pest managements are very important factor 
to consider when attempting increasing rice production. In 
Korea, Cnophalocrocis medinalis guenee is the one of 
major problem in rice cultivation especially. Generally, this 
insect can be managed using several kinds of pesticides 
(Warren et al., 1997). However, many farmers and 
consumers want to use less pesticide due to environ-
mental and economic concerns. Insect-resistant rice was 
developed to prevent pest explosions and seek eco-
friendly purposes. Many GM Crops for pest manage-
ments are developed and commercialized. Almost 32% of 
commercial GM crops are insect-resistant due to prevent 
pest damage. Almost all GM Crops use the gene as 
commonly known as Bt gene from the bacterium Bacillus 
thuringiensis that code for insecticidal crystal proteins 
were engineered into plants in the mid-1980s in order to 
develop the insect-resistant genetically modified plant. Bt 
corn was the first genetically modified by introducing the 
Bt gene since 1987 to combat the crop damage. Bt 
products have been used as insecticides for more than 
40 years without documented evidence of adverse 
effects. Additionally, a number of toxicological studies on 
insecticidal Cry proteins have not identified any safety 
concerns for using Bt proteins (McClintock et al., 1995). 
Genetic modification using insect-resistant genes is 
one of the most common modifications used to generate 
transgenic crops, including rice (Bajaj and Mohanty, 
2005; Maqbool et al., 2001; Ramesh et al., 2004; Tu et 
al., 2000; Ye et al., 2003). Commercializing GM rice lags 
behind other cereals such as maize. One reason is that 
rice is cultivated more than 100 countries around the 
world and is a staple for about a half of the world’s 
population; thus its safety must be strictly evaluated prior 
to its release to the market (Jiao et al., 2010). The cry1Ac 
gene can be isolated from B. thuringiensis and encodes 
the Cry protein, which exhibits toxic effects by forming 
pores in the cell membrane, thereby injuring epithelial 
cells in the midgut of insect. The effect is highly specific 
to target insects such as Lepidoptera and Coleoptera 
species, but is harmless to plants and mammals including 
humans (Bravo et al., 2007). We recently developed 
insect-resistant Agb0101 rice that contains the mcry1Ac1 
gene, a modified synthetic and truncated version of the 
cry1Ac1 gene that expresses the same toxic protein with 
Cry1Ac1. Agb0101 rice contains a single copy of the 
truncated cry1Ac gene, and the toxic protein expressed 
by this transgene targets the chloroplast (Lee et al., 2009). 




Furthermore, research has revealed that Agb0101 demon-
strates high resistance to rice leaf folder, rice green 
caterpillar, and rice skipper under laboratory conditions 
and to rice leaf folder under field conditions (Kim et al., 
2009).  
This study was performed to assess the toxicity of 
insect-resistant rice, develop scientific methodologies 
assess the safety of GM crops. These results could be 
used to further commercialization of insect-resistant 
Agb0101 rice. Although, this study described toxicity only, 








The modified cry1Ac1 gene (mcry1Ac1: GenBank accession no. 
AY126450) used in this study was derived from the truncated 
cry1Ac1 gene (GenBank accession no. AAA22551). This mcry1Ac1 
gene encodes the same amino acid sequences with the truncated 
Cry1Ac1 protein. For transformation into rice, some nucleotides 
were changed for optimal use in plants. Because the expression 
level of the mCry1Ac1 protein is extremely low in transgenic 
Agb0101 rice (typically less than 100 mg/kg), it is impractical for use 
in animal studies. Therefore, we conducted safety assessments 
using mCry1Ac1 protein that was produced in Escherichia coli. 
Proper characterization of the equivalence between recombinant 
and rice expressed protein is a necessary pre-requisite for use in 
safety evaluations of specific transgenic events. Agb0101 and 
control rice (Nak-dong) were grown in the experimental field of the 
National Academy of Agricultural Science (Suwon, Korea). To purify 
the mCry1Ac1 protein from rice, transgenic rice leaves containing 
the mcry1ac1 gene were used as the plant material. Samples were 
collected, and the leaves were stored at -80°C until use. 
 
 
Expression and purification of mCry1Ac1 protein from E. coli 
 
The mCry1Ac1 proteins were produced and characterized. The 
pMAL-p2g/mcry1ac1 vector (BioLabs Inc., USA) was used to 
express the mCry1Ac1 protein. mCry1Ac1 referred to the modified 
cry1ac1 gene in order to be expressed in E. coli strain BL21 
CodonPlus (DE3) RIPL (Stratagene, La Jolla, CA) as a fusion 
protein containing a maltose binding protein(MBP) tag and was 
purified using immobilized amylase resin chromatography. The MBP 
tag was cleaved from the affinity purified protein with cysteine 
protease from Tobacco Etch virus (TEV). And the fusion tag and 
TEV were removed by dialysis. For the acute toxicity study, the 
protein was lyophilized, mixed and stored at −80°C. The purity of 
the total protein was determined using sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) and scanning 
densitometry. The concentration of the total protein was determined 
using the Bradford method. The identities of both lots of proteins 
were characterized using amino acid analysis and western blot 
analysis using a proprietary mCry1Ac1- specific antibody.  
 
 
Using bioinformatic analysis to determine similarities between 
toxic proteins and the mCry1Ac1 protein 
 
Sequence similarity searches were conducted on the amino acid 
sequence of the mCry1Ac1 protein using the BLASTP algorithm of 
the  NCBI  protein  database. Sequence  similarities  were manually




Table 1. Study design of feed composition for the sub-chronic study. 
 
Ingredient (%) G1 G2 G3 G4 
No. of animals 
Male 10 10 10 10 
Female 10 10 10 10 
Agb0101 rice 0 0 5 20 
Nak-dong rice 0 20 0 0 
Feed 100 80 95 80 




inspected manually to identify known toxic proteins. Generally, a st 
atistically significant sequence similarity requires a match with an E 
score of <0.01; however, a threshold E score 1.0 provides greater 
assurance that proteins with even limited similarities will not be 
overlooked. The BLOSUM62 scoring matrix was used, low 
complexity filtering was turned off, and the number of alignments 
returned was set to a maximum value of 1,000 proteins. 
 
 
Protein sequencing and In-gel trypsin digestion and protein 
identification by MS/MS 
 
The mCry1Ac1 protein was electroporated and transferred to PVDF 
membranes. Targeted band were cut and amino acid sequencing 
was carried out by Edman Sequencer ABI494. MALDI-TOF mass 
experiments were carried out according to Sun et al. (2007), with 
minor modifications. Protein bands with mCry1Ac1 were carefully 
cut out from CBB R250-stained gels and subjected to in-gel trypsin 
digestion according to Sun et al. (2007), with minor modifications. 
MALDI-TOF/TOF-GPS Explorer™ software version 3.6 (Applied 
Biosystems) was used to create and search files with the MASCOT 
search program for peptide and protein identification.  
 
 
Acute toxicity assessments of the mCry1Ac1 protein in ICR 
mice 
 
Acute toxicity studies were conducted in accordance with OECD 
guidelines (OECD, 2001) and the Laboratory animal Act by Korea 
Food and Drug Administration (KFDA). 60 ICR mice (3 weeks old, 
18 to 22 g) were obtained from Hanlim Animal Experiment Institute, 
(Hwasung, Korea). After 5 day acclimatization period, the mice 
were randomly divided into 3 groups. Each group was related to 
mCry1Ac, Bovine serum albumin (BSA) and water as control. Each 
group contained 20 mice / group (10 males and 10 females per 
treatment). All mice were kept in stainless steel wire cages (2/cage) 
at 21 to 23°C, relative humidity 40 to 60%, 15 air change times per 
hour, and electric lights were turned on from 9 AM to 9 PM. Mice 
were allowed free access to both food and water. The mCry1Ac1 
protein was dissolved in distilled water to 95% purity, and the 
mCry1Ac1 protein concentration was adjusted to 250 mg/mL. Each 
mouse received about 0.2 mL/kg protein (2,000 mg/kg mCry1Ac1 
protein for each mouse) by gavage on the first day. BSA was used 
as the negative control and water was used as the blank control. 
Mice were given basal diet and tap water and observed for 14 days 
for any signs of morbidity or mortality. During the experimental 
period all animals were inspected twice daily (cage side). At study 
completion day 15, all animals were anaesthetized by carbon 
dioxide inhalation and sacrificed by exsanguinations for the 
subsequent gross and histopathological examinations. 
Subchronic toxicity of Agb0101 rice in SPF rats 
 
Subchronic toxicity study was conducted in accordance with OECD 
guidelines (OECD, 1998) and the Laboratory animal Act by KFDA. 
80 SPF rats (40 male and 40 female) were obtained from Orient Co. 
(Kapyung, Korea). All rats were 5 weeks old at study initiation. 
Following a 7 day acclimatization period, they were randomly 
divided into 4 groups, 20 mice/ group (10 males and 10 females per 
treatment). All diets were administered to rats for 90 consecutive 
days. Animals were housed pair wise in stainless steel wire cages 
at 23 ± 2°C, relative humidity 55 ± 5%, 10 to 15 air change per hour 
and electric light with 200 to 300 lux from 9 AM to 9 PM. Rats were 
allowed free access to both food and water. Insect resistant 
Agb0101 rice was mixed with the basal diet in order to take into 
account nutritional balance. We made 4 kinds of feed for this 
experiment. The composition of the feed administrated to each 
group is listed in Table 1. Diets were identically adjusted to assure 
an adequate supply of macronutrients and vitamins after 
substitution with 60% rice, but no adjustments were made to 
balance differences in the constitution of the rice (as observed by 
the compositional/chemical analyses). Rats were allowed free 
access to both food and water (KFDA, 2007). 
 
 
Serum biochemistry and haematology  
 
All animals were fasted overnight to minimize fluctuations in the 
measured parameters. Blood samples were taken from the eyeball 
veniplex and stabilized using heparin. The following biochemical 
parameters were measured: alkaline phosphatase (ALP), alanine 
aminotransferase (ALT), aspartate aminotransferase (AST), urea 
nitrogen (BUN), triglyceride (TG), albumin/globulin ratio (A/G ratio), 
inorganic phosphorus (IP), sodium, potassium, cholesterol, protein, 
albumin, creatinine and glucose. All analyses on blood plasma were 
performed on a Express plus (Bayer Diagnostics Inc., USA). Blood 
samples used to assess the hematology characteristics were 
stabilized using EDTA. The following characteristics were assessed 
using the Baker system 9118 Hematology Analyzer (Biochem 
Immunosystems Inc., Allentown, PA). White blood cells, Red blood 
cells, hemoglobin concentration, hematocrit, mean cell volume, 
mean cell hemoglobin, mean cell hemoglobin concentration and 
platelet count. The differential count distinguishes between 
basophils, eosinophils, lymphocytes, monocytes and neutrophils. 
 
 
Organ weights, gross necropsy and histopathology 
 
Necropsy was performed and the following organs were sequentially 
excised: brain, thymus, heart, lungs, liver, spleen, stomach, 
duodenum, adrenals, kidneys, ovaries, and testes. The brain, heart, 





were immediately weighed, and the stomach, duodenum, kidneys 
and liver were immediately fixed in 4% buffered formaldehyde for 
histological processing. Tissue samples were embedded in paraffin, 
and sectioned to 3 to 5 μm thick, and then stained with standard 





Statistical comparisons were designed to determine if differences in 
the mentioned response variables between groups could be 
attributed to the mCry1Ac1 protein and Agb0101 rice. Data 
obtained from the mCry1Ac1 protein groups were compared with 
the values from the vehicle and BSA control groups. Similarly, each 
Agb0101-treated group was compared with the values from the 
control groups. Homogeneity variance was analyzed using one-way 
analysis of variance (ANOVA) using Statistical Product and Service 
Solutions (SPSS) v12.0 (SPSS Inc., Chicago, IL). Differences were 
considered significant when p<0.05 and then a step-down analysis 





BlastP comparison of the mCry1Ac1 proteins to other 
toxic proteins  
 
BLASTP similarity searches were conducted using the 
amino acid sequence of mCry1Ac1 in order to identify the 
1000 closest matches. The highest E score returned was 
0.85, confirming that sequences with limited similarity 
were not overlooked by the search. 95 of the accessions 
returned by the searches demonstrated complete 
significance (E = 0) and represent very closely related 
Cry proteins from various bacterial species. A total of 827 
other sequences were identified as Cry proteins from 
various bacterial species. The remaining 173 hits 
represented a variety of proteins that are all functionally 
related by the possession of one or more well characterized 
conserved thiamine pyrophosphate binding domains. No 
information is available on the toxicity of these proteins 
returned by the BLASTP search identified similarities to 
proteins known toxic. Assessing the safety of a novel 
protein requires determining its amino acid sequence 
similarity with known toxic proteins that have potential 
safety concerns. Accordingly, amino acid sequences were 
compared as part of the current food safety decision tree 
strategy as recommended by FAO/WHO (2001) and the 
CODEX (2003). Amino acid sequence similarities 
between the mCry1Ac1 protein and known toxic proteins 
were determined according to published guidelines 
(CODEX, 2003). The results of the in silico analysis 
revealed no evidence for similarities between mCry1Ac1 
and any known toxic protein. 
 
 
Isolation and characterization of heterologously 
produced mCry1Ac1 protein 
 
The recombinant mCry1Ac1 protein was expressed in E. 
coli  and  purified  as  a  soluble  protein.  The  mCry1Ac1 




protein migrated as a major band and demonstrated a 
molecular weight of approximately 66 kDa according to 
our SDS–PAGE analysis. The purity of the mCry1Ac1 
protein was greater than 95% according to densitometry 
analysis which was performed the SDS–PAGE analysis 
(Figure 1). After blotting to PVDF membrane, we 
performed N-terminal sequencing by Edman degradation. 
The N-terminal sequence of the analyzed mCry1Ac1 
protein was identical to deduced amino acid sequence of 
mCry1Ac1. MALDI-TOF MS analysis confirmed 71% 




Acute toxicity of mCry1Ac1 protein 
 
The acute toxicity of the mCry1Ac1 protein was assessed 
in mice following the oral administration of the purified 
heterologously expressed protein at 2,000 mg/kg body 
weight of the test substance (corresponding to approxi-
mately 2,000 mg/kg of body weight of mCry1Ac1 protein) 
via oral gavage. Control groups were administered either 
vehicle (that is, water) alone or BSA at 2,000 mg/kg body 
weight. All mice survived the study period and no clinical 
signs of systemic toxicity were observed in any treatment 
groups (data not shown). All mice in all treatment groups 
gained weight relative to day 0 of dosing (Table 2), and 
no gross lesions were present in any of the mice at 
necropsy, thereby indicating that the mCry1Ac1 protein 
was not acutely toxic. The mCryAC1 protein demon-
strates no special toxicity according to our acute toxicity 
tests. We did not observe animal death and special 





Subchronic toxicity of genetically modified rice 
Agb0101 
 
Mortality and clinical signs  
 
There was no instance of treatment-related mortality in 
the animals treated with Agb0101 rice during this study. 




Body weight and feed consumption 
 
No reliable differences in body weight (Figure 2), feed 
consumption, weight gains, or food efficiency were 
observed between rats in the Agb0101-treated groups 
and those in the related control group (that is, rat that 
received Nak-dong rice). Also, no reliable changes in 
consumption between treated groups were observed 





As shown in Table 3, no significant changes were observed 










Figure 1. Purification of microbial mCry1Ac1 protein. (A). SDS-PAGE analysis of microbial mCry1Ac1 protein. Lane 1 
contains total cell extract; Lane 2 contains soluble fraction of cell extract; Lane 3 contains amylase resin eluted 
fraction; Lane 4 contains concentrate of amylase resin eluted fraction; Lane 5 contains anion-exchange 
chromatography eluted fraction. (B). The Cleavage of MBP-mCry1Ac1 protein. Lane M contains molecular weight 





Table 2. Body weights changes of mice from acute toxicity study with mCry1Ac1 protein. 
 
Materials 
Female                        Male 
0 7 14 0 7 14 
m Cry1Ac1 22.1±0.79 24.6±1.36 26.8±1.41 31.5±1.34 34.3±1.77 37.6±1.96 
BSA 22.7±1.66 25.5±1.93 26.6±1.95 31.6±1.83 35.0±3.23 38.4±3.35 




in most of the hematology response variables between 
groups that consumed the different diets. However, 
certain hematology variables, such as reticulo-cytes in the 
male rats in the G4 group demonstrated significant 
decrease in comparison with G1 whereas female in the 
G3 and G4 groups demonstrated significant increases in 
comparison with G1, G2 groups. Reticulocytes are a 
known indicator of anemia, but related variables like red 
blood cells, hemoglobin, and hematocrit did not 
significantly changed in either males or females. These 
results indicate that the reticulocyte changes in males 





No differences were observed in most of the values of the 
serum response variables between the groups consumed 
different diets (Table 4). However, some differences were 
observed in total protein and some ion parameters. Total 
protein demonstrated a significant decrease among 
female in the G4 and G1 groups. However, this value 
difference was not observed in the G2 group females. 
Calcium ion also statistically and significantly decreases 
in G3 and G4 females, but not in males, though this 
finding was not significantly between the G1 and G4 
groups. Chloride ion decreased in G3 and G4 males in 
comparison with G1 males, but increased in G4 female 
comparison with G1 females. These changes were not 
consistently demonstrated in males and females, and the 
increases/decreases were inconsistent. Therefore, the 
observed differences in these parameters are attributed 
to background variability and sporadic deviation. All 
differences are within the normal ranges for rats. 
Therefore, they are not considered related to Agb0101 
rice. 
































   











































Figure 3. Feed consumption of rats orally treated with Agb0101 rice for 90 days. 









G 1 G 2 G 3 G 4 
Male 
Basophils(%) 0.06±0.03 0.03±0.02 0.04±0.02 0.03±0.02 
Eosinophils (%) 0.42±0.27 0.35±0.23 0.44±0.21 0.53±0.34 
Hematocrit (%) 42.54±3.61 42.53±2.62 42.08±3.90 44.55±3.94 
Hemoglobin (g/dl) 16.42±0.74 16.57±1.04 16.48±0.92 17.06±0.61 
Lymphocytes (%) 47.35±3.72 48.45±5.83 46.44±8.04 43.54±6.41 
Monocytes (%) 9.92±1.71 11.87±3.05 11.32±4.64 14.35±4.21 
Neutrophils (%) 37.28±3.49 38.83±4.61 41.75±6.01 41.51±6.14 




) 7.82±1.06 7.82±0.53 8.01±0.59 8.37±0.64 
Reticulocyte (%) 0.93±0.21 0.91±0.22 0.82±0.18 0.69
a
±0.10 




) 7.67±2.29 8.17±2.09 7.88±2.46 5.92±1.89 
Activated Partial Thromboplastin Time (sec) 23.74±2.87 22.65±2.10 22.76±1.75 23.63±3.41 
Prothrombin Time (sec) 20.58±3.26 19.82±1.74 18.98±1.45 19.64±3.24 
Mean Corpuscular Hemoglobin (pg) 21.13±1.37 21.61±0.91 20.84±2.82 21.49±2.36 
Mean Corpuscular Hemoglobin Concentration (g/dl) 38.39±2.14 39.07±1.84 39.37±2.45 38.44±2.38 
Mean Corpuscular Volume (fL) 53.37±3.45 54.56±2.82 52.63±2.43 52.81±2.84 
 
     
Female 
Basophils (%) 0.03±0.02 0.03±0.02 0.05±0.03 0.04±0.02 
Eosinophils (%) 0.76±0.44 0.61±0.25 0.63±0.23 0.71±0.47 
Hematocrit (%) 42.58±4.32 42.85±5.11 39.83±6.87 44.35±5.14 
Hemoglobin (g/dl) 15.28±0.72 15.83±1.21 15.65±0.79 15.32±1.59 
Lymphocytes (%) 53.82±7.91 48.94±7.89 55.64±9.85 50.97±9.52 
Monocytes (%) 10.03±2.66 11.48±1.77 10.69±2.82 11.31±2.26 
Neutrophils (%) 35.44±7.31 39.53±7.92 34.53±9.25 37.08±8. 43 




) 7.51±1.05 7.65±0.88 7.39±1.32 7.87±0.78 









) 3.68±1.38 3.53±1.51 3.25±0.75 4.18±1.29 
Activated Partial Thromboplastin Time (sec) 21.57±1.46 21.13±1.30 22.03±1.85 21.28±1.18 
Prothrombin Time(sec) 15.69±1.23 15.84±0.67 16.34±0.61 16.37±0.60 
Mean Corpuscular Hemoglobin (pg) 21.11±1.75 21.35±1.94 22.47±5.63 19.85±1.55 
Mean Corpuscular Hemoglobin Concentration (g/dl) 36.78±2.29 38.89±3.69 40.16±9.71 35.39±3.75 
Mean Corpuscular Volume (fL) 55.91±2.05 55.78±2.26 54.86±1.88 55.33±2.96 
 
Significant differences as compared with G1: 
a
P < 0.05. Significant differences as compared with G2 : 
b




Necropsy findings and organ weight 
 
There were no gross indications of adverse effect in any 
rat organs on necropsy. No statistically significant 
differences were observed in the mean relative organ 
weights between the different treatment groups and the 
control group (Table 5). Additionally, no adverse effects 
were noted on histopathological observation (Table 6). 
Insect-resistant Agb0101 rice was mixed with normal feed 
at two different concentrations, 5 and 20%. The amounts 
of protein incorporated into the diet of each groups were 
92 and 132 mg/Kg, respectively. As control groups, 
normal Nak-dong rice also mixed with normal feed into 
the diet at 20%. Over the course of the in-life phase of 
this study, no statistically significant differences in body 
weights (Figure 2) or feed consumption were observed 
between the control groups and the groups that 
consumed Agb0101 rice-containing diets (Figure 3). The 
consumed doses of mCry1Ac1 protein averaged 0.42 
and 1.62 mg/kg body weight/day in males and 0.3 and 
1.3 mg/kg body weight/day in females that calculate from 





This  study  describes  our  toxicity  assessment  that was 










G 1 G 2 G 3 G 4 
 T-Protein (g/dl) 6.01±0.17 6.09±0.25 6.16±0.22 6.09±0.20 
 Albumin (g/dl) 2.29±0.16 2.34±0.08 2.28±0.12 2.35±0.11 
 A/G ratio 0.62±0.26 0.62±0.13 0.59±0.07 0.63±0.09 
 ALP (IU/L) 203.2±44.38 208.1±38.57 202.6±38.32 186.2±39.15 
 AST (IU/L) 101.7±29.47 98.9±18.38 97.8±17.89 103.5±14.88 
 ALT (IU/L) 38.9±5.65 39.5±6.23 39.7±8.91 38.5±6.83 
 BUN (mg/dl) 14.76±2.38 15.06±1.79 16.94±2.41 17.16±2.38 
 Cholesterol (mg/dl) 68.6±15.44 71.4±16.06 72.5±10.84 70.5±7.79 
Male Creatinine (mg/dl) 0.54±0.06 0.55±0.06 0.56±0.06 0.56±0.08 
 Glucose (mg/dl) 164.1±36.28 170.0±17.68 165.2±34.92 165.9±19.93 
 TG (mg/dl) 83.83±39.65 84.10±36.92 82.30±26.81 73.40±19.76 
 Calcium (mg/dl) 10.19±0.62 9.96±0.61 10.84±0.55 9.98±0.43 





 IP (mg/dl) 6.13±0.85 6.24±0.67 5.99±0.49 6.13±0.54 
 K+(mmol/L) 4.32±0.83 4.33±0.56 4.46±0.45 4.53±0.47 
 Na+(mmol/L) 145.1±1.45 143.8±1.94 146.3±1.62 145.7±1.46 
 
     
 T-Protein (g/dl) 7.27±0.23 6.92±0.29 6.95±0.32 6.78
a
±0.28 
 Albumin (g/dl) 3.19±0.21 3.15±0.33 3.19±0.17 2.96±0.33 
 A/G ratio 0.78±0.09 0.84±0.11 0.85±0.08 0.77±0.13 
 ALP (IU/L) 103.1±45.43 98.7±20.21 93.8±24.55 96.5±20.19 
 AST (IU/L) 123.9±31.14 99.1±24.88 93.6±26.31 101.5±27.65 
 ALT (IU/L) 41.8±19.23 36.7±22.44 39.5±10.86 38.9±20.42 
 BUN (mg/dl) 16.45±2.32 17.14±2.43 18.34±3.97 17.18±1.81 
 Cholesterol (mg/dl) 85.1±12.77 84.4±17.30 89.2±19.31 87.1±13.11 
Female Creatinine (mg/dl) 0.63±0.11 0.67±0.06 0.65±0.13 0.64±0.09 
 Glucose (mg/dl) 139.4±16.22 140.5±15.37 142.3±11.19 139.3±11.27 
 TG (mg/dl) 11.6±6.86 10.3±3.54 9.7±3.85 12.5±11.06 









 Cl-(mmol/L) 109.1±2.03 108.5±1.47 108.1±3.08 124.2 
a,b
±4.93 
 IP (mg/dl) 5.81±1.48 5.55±1.13 5.72±0.52 5.65±0.83 
 K+(mmol/L) 3.97±0.45 3.93±0.33 4.03±0.29 3.99±0.23 
 Na+(mmol/L) 145.9±1.25 145.9±1.61 146.1±1.78 146.3±1.32 
 
Significant differences as compared with G 1 : 
a
P < 0.05. Significant differences as compared with G 2 : 
b




conducted on the mCry1Ac1 protein and Agb0101 rice. 
This assessment evaluates the potential toxicity of 
transgenic proteins using weight-of-evidence and tiered 
approaches, respectively (CODEX, 2003; EC 2003). No 
evidence for potential toxicity was identified for the 
mcry1Ac1 gene according to the components of a first 
tier. The bt gene was obtained from Bacillus sp., which 
has a long history of safe use in agricultural pesticides. 
Rice also has a long safe history as a common component 
of the human diet. Human exposure to the mCry1Ac1 
protein is most likely extremely low because it is present 
at low concentrations in the entire genetically modified 
Agb0101 rice plant. The effects of the mCry1Ac1 protein 
determined by the 90-day toxicity study should be 
considered in comparison to the concentration determined 
in rice seeds obtained from genetically modified insect- 
resistant Agb0101 rice as determined using mCry1Ac1-
specific ELISA (0.2 mg/Kg mCry1Ac1 protein in dry 
tissue). The average human (average body weight 60 kg) 
would need to consume about 60 kg/day of grain 
expressing the mCry1Ac1 protein to approximate the 
same daily dose consumed by the high dose group enrolled 




Table 5. Organ weight in treated rat. 
 
Sex Organ weight group (n=10) G 1 G 2 G 3 G 4 
 Terminal body weight 538.59±50.02 555.67±50.38 522.95±48.67 543.07±46.14 
 Adrenal gland 0.029±0.004 0.028±0.005 0.026±0.004 0.029±0.005 
 Brain 2.11±0.08 2.12±0.06 2.12±0.09 2.12±0.08 
 Epididymis 0.73±0.08 0.74±0.11 0.73±0.06 0.75±0.06 
Male Heart 1.67±0.15 1.68±0.18 1.71±0.13 1.72±0.14 
 Kidney 1.53±0.15 1.52±0.12 1.51±0.17 1.55±0.16 
 Liver 12.58±1.61 12.77±1.62 12.94±1.94 12.42±1.33 
 Pituitary gland 0.014±0.002 0.013±0.002 0.014±0.003 0.016±0.005 
 Spleen 0.73±0.12 0.74±0.25 0.73±0.19 0.75±0.16 
 Testis 1.73±0.22 1.69±0.24 1.68±0.21 1.72±0.18 
 Thymus 0.39±0.11 0.41±0.10 0.38±0.10 0.39±0.13 
 
     
 Terminal body weight 291.72±25.41 289.71±25.64 299.38±26.40 301.62±28.89 
 Adrenal gland 0.034±0.007 0.034±0.006 0.033±0.007 0.034±0.005 
 Brain 2.01±0.10 2.04±0.10 2.03±0.09 2.01±0.09 
 Heart 1.17±0.21 1.17±0.26 1.09±0.14 1.15±0.21 
 Kidney 0.91±0.13 0.89±0.13 0.88±0.14 0.94±0.15 
Female Liver 7.45±0.84 7.25±0.69 7.35±0.87 7.55±0.86 
 Pituitary gland 0.020±0.004 0.019±0.004 0.018±0.005 0.017±0.007 
 Spleen 0.51±0.08 0.49±0.06 0.48±0.07 0.50±0.06 
 Testis 0.060±0.013 0.062±0.012 0.057±0.014 0.062±0.010 




Table 6. Histopathological findings of rats treated with GM rice for 90 days. 
 
Histopathological finding  
Sex Male Female 
Group(n=10) G1 G4 G 1 G4 
Liver 
Portal inflammatory cells  9(1) 10(0) 10(0) 10(0) 
Centrilobular apoptosis/vacuolation  10(0) 10(0) 10(0) 10(0) 
Medullary mineralization 10(0) 10(0) 10(0) 10(0) 
Periportal vacuolation 10(0) 10(0) 10(0) 10(0) 
Medullary mineralization  10(0) 10(0) 10(0) 9(1) 
Parenchymal inflammatory cells 10(0) 10(0) 10(0) 9(1) 
Cortical scarring and inflammatory cells 10(0) 10(0) 10(0) 9(1) 
      
Kidney 
Papillary mineralization 9(1) 10(0) 10(0) 10(0) 
Inflammatory cells 9(1) 9(1) 10(0) 9(1) 
Cortical vacuolation 10(0) 10(0) 10(0) 10(0) 
Basophilia 10(0) 10(0) 10(0) 10(0) 
      
Adrenal gland 
Cortical hypertrophy 9(1) 9(1) 10(0) 10(0) 
Cortical vacuolation 10(0) 6(4) 10(0) 9(1) 
      
Heart 
Myocardial inflammation  8(2) 9(1) 9(1) 10(0) 
Endocardial inflammation 10(0) 10(0) 10(0) 10(0) 
Myocardial fibrosis & inflammation 10(0) 10(0) 10(0) 10(0) 
Myocardial necrosis 10(0) 9(1) 10(0) 10(0) 




Table 6. Contd. 
 
 Myocardial hemorrhage 10(0) 9(1) 10(0) 9(1) 
      
Lung 
Alveolar macrophage 9(1) 9(1) 10(0) 10(0) 
Pneumonitis 9(1) 9(1) 10(0) 10(0) 
Perivascular inflammatory cells 8(2) 10(0) 8(2) 10(0) 
Alveolar osseous metaplasia 9(1) 9(1) 10(0) 10(0) 
Prominent BALT 9(1) 8(2) 8(2) 10(0) 
Alveolar hemorrhage 10(0) 10(0) 10(0) 10(0) 
Pigmented macrophage 10(0) 10(0) 10(0) 10(0) 
      
Spleen 
Extramedullary hematopoiesis 8(2) 6(4) 8(2) 6(4) 
Subcapsular vacuolation 9(1) 10(0) 10(0) 10(0) 
Hemosiderosis 10(0) 10(0) 10(0) 10(0) 
      
Epididymis/ Prostate gland 
Interstitial infiltration cells 9(1) 10(0)   
Prostatitis 9(1) 9(1)   
Interstitial inflammatory cells 9(1) 10(0)   
      
Uterus 
Luminal dilatation   7(3) 8(2) 
Endometrial glandular dilatation   10(0) 10(0) 
      
Thymus 
Involution / atrophy 9(1) 10(0) 10(0) 8(2) 
Cortical apoptosis 10(1) 10(0) 10(0) 10(0) 
Cystcs 10(0) 10(0) 10(0) 10(0) 
      
Thyroid gland 
Microfollicles 9(1) 10(0) 10(0) 10(0) 
Follicular cell hypertrophy 10(0) 10(0) 10(0) 10(0) 
      
Pancreas 
Focal acinar atrophy 9(1) 10(0) 10(0) 10(0) 
Fat replacement 9(1) 10(0) 10(0) 10(0) 
Acinar apoptosis 7(3) 8(2) 9(1) 10(0) 
Inflammatory cells 10(0) 10(0) 10(0) 10(0) 
      
Stomach 
Submucosal inflammation 9(1) 10(0) 10(0) 9(1) 
Squamous cyst 9(1) 10(0) 10(0) 10(0) 
Ulceration-non glandular region 10(0) 10(0) 9(1) 10(0) 
      
Urinary bladder Luminal dilatation 10(0) 9(1) 9(1) 10(0) 
 




in the 90-day toxicity study. This is an extremely conser-
vative estimate of human exposure to the mCry1Ac1 
protein because in vitro digestion studies indicate that 
mCry1Ac1 will not be absorbed intact because it will most 
likely be degraded within the gut.  
Dietary proteins are taken in as nutrients and typically 
demonstrate no relation to toxic effects. However, some 
proteins do cause acute toxicity (Metcalfe et al., 1996; 
Sjoblad et al., 1992). For this reason, guidance documents 
from CODEX and KFDA described procedures for 
assessing the potential toxicity of transgenic proteins. 
Most dietary proteins are non-toxic and absorbed for 
nutritional purposes. However, because some identified 
proteins are toxic to mammals and other species, new 
reliable recommendations were developed to assess 
transgenic proteins that could cause toxicity using a two-
tiered approach (Delaney et al., 2008).  
The first tier assesses the history of use of the 
organism from which the gene is obtained. Generally, 
similarities between known toxic proteins and transgenic 
proteins can be determined using bioinformatical 
analysis, mechanism of action of the protein, in vitro 
stability to digestive enzymes were major research 
process (Delaney et al., 2008). A second tier analysis 
may be conducted if there have harmful results. Elements 
within this tier include acute toxicity studies that use 
purified transgenic proteins and 90-days oral toxicity 
(sub-chronic) studies with genetically modified organisms  









Our present data demonstrate the safety of the 
mCry1Ac1 protein and insect-resistant Agb0101 rice for 
use in food and feed applications and indicate that the 
mCry1Ac1 protein and Agb0101 rice presents no risks for 
adverse health effects when used in the context of 
agricultural biotechnology. No evidence of toxicity was 
observed in mice or rats following acute or 90-day oral 
exposure to heterologously produced mCry1Ac1 protein 
in Agb0101 rice. Therefore, according to our current study 
findings, the no-observed-adverse-effect-level (NOAEL) 
for the mCry1Ac1 protein is more than 10 g/Kg body 
weight for both male and female mice. Results from these 
studies further support the use of a tiered approaches 
that include Tier II studies, such as including hazard 
characterizations and acute and sub-chronic oral toxicity 
studies, but do not provide additional information or 
results that contradict the results of the Tier I studies that 
do not identify evidence for potential toxicity of the 
mCry1Ac1 protein.  
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